Skip to main content
Premium Trial:

Request an Annual Quote

Cellink to Distribute SeqWell Single-Cell Sequencing, NGS Sample Prep Products

NEW YORK — Cellink said on Monday that it has signed an agreement to commercialize a range of SeqWell's single-cell RNA sequencing and sample preparation products outside of the US.

Under the terms of the deal, Cellink will sell in ex-US markets SeqWell's PlexWell Single-Cell Rapid Kit for plate-based single-cell RNA sequencing, which is set to launch later this month, as well as its full line of PlexWell next-generation sequencing library preparation kits.

The companies have also agreed to collaborate on new multiplex genomic assay products.

Additional terms of the deal were not disclosed.

Last month, Sweden-based Cellink signed a distribution agreement for Phasefocus' Livecyte high-content live-cell imaging platform. About a year ago, Beverly, Massachusetts-based SeqWell raised $9 million in Series B funding. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.